Author

Sushmitha Sriramulu

Henry Ford HealthORCID 0000-0001-7992-5249Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Sushmitha Sriramulu1 paper · Henry Ford Health

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Anna A. SchwendemaniD· 1 shared Anzar MujeebiD· 1 shared Benjamin MovsasiD· 1 shared Farzan SiddiquiiD· 1 shared Kaushik BanerjeeiD· 1 shared Li LiuiD· 1 shared Maria Graciela CastroiD· 1 shared Maya U. ShethiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna A. SchwendemanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting NF-κB epigenetic activation and DNA repair deficiency in G34-mutant pediatric diffuse hemispheric glioma with nanoparticles combining PARP inhibition and immune stimulation mediated by CpG dinucleotides

Santiago Haase, Kaushik Banerjee, Anzar Mujeeb, Troy A. Halseth, Li Liu, Minzhi Yu, Sushmitha Sriramulu, Maya U. Sheth, Sadhakshi Raghuram, Pedro Ricardo Lowenstein, Anna A. Schwendeman, Maria Graciela Castro

bioRxiv · Mar 11, 2026 · PreprintCancer Biology

BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy

Shivani Thoidingjam, Sushmitha Sriramulu, Oudai Hassan, Stephen L. Brown, Farzan Siddiqui, Benjamin Movsas, Shirish M. Gadgeel, Shyam Nyati

This study shows BUB1 inhibition enhances the effectiveness of radiotherapy and chemoradiation in lung cancer cell lines.

Cancers · Sep 27, 2024Peer-reviewedCancer Biology